Showing results (371-380 of 438) with videos related to
Sort By:
Pageof 44
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.The Cochrane Database of Systematic Reviews|May 5, 2017
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel diseaseClaudio A Bravo, Sameer A Hirji, Deepak L Bhatt, et al.Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.Journal of the American College of Cardiology|March 25, 2017
Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized TrialsEmily S Lau, Eugene Braunwald, Sabina A Murphy, et al.Cerebrovascular Diseases (Basel, Switzerland)|March 14, 2008
Risk factor profile and management of cerebrovascular patients in the REACH RegistryJoachim Röther, Mark J Alberts, Emmanuel Touzé, et al.American Heart Journal|February 22, 2022
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practicesWilliam W O'Neill, Mark Anderson, Daniel Burkhoff, et al.JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.Journal of Cardiac Failure|July 21, 2023
Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical TrialsNathan P Goodwin, Robert M Clare, Josephine L Harrington, et al.American Heart Journal|September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trialJose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.Pageof 44